Virus Barrier Plus
Sodium Chlorite
Wooju Mulsan Co., Ltd
Human Otc Drug
NDC 79928-201Virus Barrier Plus also known as Sodium Chlorite is a human otc drug labeled by 'Wooju Mulsan Co., Ltd'. National Drug Code (NDC) number for Virus Barrier Plus is 79928-201. This drug is available in dosage form of Stick. The names of the active, medicinal ingredients in Virus Barrier Plus drug includes Sodium Chlorite - 20 g/100g . The currest status of Virus Barrier Plus drug is Active.
Drug Information:
| Drug NDC: | 79928-201 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Virus Barrier Plus |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Sodium Chlorite |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Wooju Mulsan Co., Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Stick |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SODIUM CHLORITE - 20 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 31 Jul, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Wooju Mulsan Co., Ltd
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 8809509350003
|
| UPC stands for Universal Product Code. |
| UNII: | G538EBV4VF
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 79928-201-01 | 5 g in 1 CASE (79928-201-01) | 31 Jul, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose viral removal, removal of mold, sterilization, removal of allergic substances, deodorization, prevention of rhinitis
Product Elements:
Virus barrier plus sodium chlorite sodium hydroxide magnesium trisilicate sodium chlorite chlorite ion
Indications and Usage:
Directions 1 open the chlorine dioxide from the sealed package. 2 put the chlorine dioxide in the case. 3 close the case. 4 connect the necklace strap on the top of case. 5 the case can be used by the employee card or card holder.
Warnings:
Caution do not eat or do not put in the mouth. when the product is put in the eye, wash down with the water.
Dosage and Administration:
Usage of case - it is available for using the employee card, cerdit card or name card. - after removing the strap, it can use the clip. - it can put in the breast pocket. - when sleeping, it is better to put near by the bed. - it is good to put in the car or the refrigerator.
Package Label Principal Display Panel:
Package label 5g ndc: 79928-201-01 label 1 5g ndc: 79928-201-01 label 2